Notable Labs, Ltd. NTBLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow NTBLQ
Growth Flags
show if company had growth for consecutive years
| Jun '24 | Mar '24 | Dec '23 | Sep '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.11 | 0.64 | — | — |
+8 more quarters Free account |
P/S ratio |
0.00 | 0.00 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(1.50) | (4.28) | — | — | |
P/B ratio |
0.78 | 1.32 | — | — | |
Price to Tangible BV |
0.78 | 1.32 | — | — | |
EV/Sales |
(10.31) | (70.31) | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(0.11) | (0.51) | — | — | |
EV/FCF |
(0.11) | (0.51) | — | — | |
Quick Ratio |
1.63 | 3.25 | 4.32 | 7.98 | |
Current Ratio |
2.77 | 4.66 | 5.65 | 8.05 | |
Net Debt/EBITDA |
0.73 | 2.10 | 2.12 | 20.69 | |
Debt/Assets |
2.04% | 1.56% | 1.35% | 0.00% | |
Debt/Equity |
0.03 | 0.02 | 0.02 | 0.00 | |
Asset Turnover |
(0.01) | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.71 | 0.95 | 12.40 | 1.69 | |
Capex/Depreciation |
(0.12) | (0.10) | (29.26) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
117,700.00% | 155,000.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
151,400.00% | 228,900.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
45,950.00% | 13,200.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.57 | 0.50 | — | — | |
Graham Number |
9.80 | 8.71 | — | — | |
Earnings Yield |
952.68% | 155.68% | — | — | |
Free Cash Flow Yield |
(272.50%) | (94.62%) | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.39) | (0.39) | (1.84) | (0.81) | |
Capex per Share |
0.00 | 0.00 | (2.28) | 3.34 | |
Free Cash Flow per Share |
(0.39) | (0.40) | (4.12) | 2.54 | |
Cash per Share |
0.43 | 0.91 | 3.58 | 9.28 | |
Shareholders Equity per Share |
0.76 | 1.28 | 4.58 | 8.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.76 | 1.28 | 4.58 | 8.19 | |
Free Cash Flow |
(3.72) | (3.57) | (13.59) | 5.68 | |
Working Capital |
4.47 | 9.20 | 12.73 | 18.34 | |
Capital Expenditures |
(0.01) | (0.01) | (7.52) | 7.48 | |
Net Current Asset Value |
3.17 | 7.66 | 11.04 | 18.34 | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
4.00 | 6.00 | 0.00 | 0.00 | |
Net Profit Margin |
(260,950.00%) | (376,600.00%) | 0.00% | 0.00% | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
1.71 | 4.65 | 1.31 | 4.88 | |
Average Assets |
17.83 | 21.86 | 12.53 | 28.23 | |
Average Common Equity |
13.21 | 15.72 | (10.93) | 21.82 |
Columns are period end dates